Evgen evgen.com


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

Evgen Pharma is a clinical stage drug development company focused on cancer and neurological disease. The company is focused in the development of pharmaceuticals that activate the antioxidant response element, Nrf2. It's pipeline is based on Sulforadex technology, and includes a number of synthetic, stabilized analogues of the naturally occurring compound sulforaphane. Many peer-reviewed scientific papers have identified the medical potential of sulforaphane in multiple indications. Evgen's obj...Show all

Evgen Pharma is a clinical stage drug development company focused on cancer and neurological disease. The company is focused in the development of pharmaceuticals that activate the antioxidant response element, Nrf2. It's pipeline is based on Sulfora...Show all

Company (IPO / Went public)

Phone: +44 (0) 151 705 3532

Fax:

Liverpool Science Park
Innovation Centre 2, 146 Brownlow Hill
Liverpool, L3 5RF
United Kingdom

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Evgen $15M Oct 21, 2015

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Evgen Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Innovate UKGovernmentWiltshire, England, United KingdomGrant
Rising Stars Growth FundSeries A
North West Fund for BiomedicalVenture CapitalWarrington, United KingdomSeries A - II, Series A
Enterprise VenturesVenture CapitalPreston, England, United KingdomSeries A - II
Sarum CapitalVenture CapitalMonmouthshire, United KingdomSeries B, Series A - II
See all 8 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)